Cargando…
Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report
INTRODUCTION: Ticlopidine is a platelet inhibitor used to prevent thrombosis in patients with cerebrovascular or coronary artery disease. The most common side effects are mild and transitory: diarrhea, dyspepsia, nausea and rashes. More serious, but less frequent, adverse effects are hematological d...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924862/ https://www.ncbi.nlm.nih.gov/pubmed/20704700 http://dx.doi.org/10.1186/1752-1947-4-269 |